Clinical Trials Logo

Clinical Trial Summary

The aim of the study is to evaluate the impact of atrial fibrillation ablation in patients presenting a brady-tachy syndrome on the AF burden.

The hypothesis of the study is that AF ablation prevents not only from AF episodes recurrence but also from bradycardic episodes.


Clinical Trial Description

The study is a randomized study 1:1 AF ablation vs non AF ablation. Patients are followed for 1 year. 38 patients will be required to show a significant reduction in AF burden. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT00740272
Study type Interventional
Source Abbott Medical Devices
Contact
Status Terminated
Phase N/A
Start date March 2008
Completion date December 2009

See also
  Status Clinical Trial Phase
Recruiting NCT00224341 - Arrhythmia Restart Prevention and RatE STabilization in Atrial Fibrillation Phase 4
Recruiting NCT04905199 - Temporary Transvenous Pacemaker Placement by Intracavitary Electrocardiogram Monitoring
Recruiting NCT04858698 - Reduction Or Elimination Of Radiation During Implantation of Cardiac Devices Using Ultrasound N/A
Completed NCT04632641 - Suture Closure AFtEr VEIN Access for Cardiac Procedures (SAFE-VEIN) Trial N/A